Full metadata record

DC FieldValueLanguage
dc.contributor.author배상철-
dc.date.accessioned2016-09-20T00:23:43Z-
dc.date.available2016-09-20T00:23:43Z-
dc.date.issued2015-03-
dc.identifier.citationINTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, v. 18, NO 3, Page. 315-322en_US
dc.identifier.issn1756-1841-
dc.identifier.issn1756-185X-
dc.identifier.urihttp://onlinelibrary.wiley.com/doi/10.1111/1756-185X.12515/abstract;jsessionid=C509E1ED7EC14FA668D82750F4A0888D.f01t04-
dc.identifier.urihttp://hdl.handle.net/20.500.11754/23217-
dc.description.abstractAim The aim of this study was to evaluate the occurrence of active tuberculosis (TB) in patients who received both an interferon-gamma release assay (the QuantiFERON-TB Gold In-Tube test [QFT-GIT]) and tuberculin skin test (TST) in comparison with those who received QFT-GIT or TST alone for the detection of latent TB infection (LTBI). Methods In total, 842 patients who received QFT-GIT or TST and used biologic agents between January 2007 and December 2012 were recruited to determine the usefulness of LTBI screening tests. The incidence of active TB was calculated relative to the LTBI screening method as the number of events per 100000 person-years exposure. Results TB occurred in two of the patients who complied with an LTBI prophylaxis strategy. The TB incidence in the group that received both QFT-GIT and TST was 151.05 (95% confidence interval [CI] 150.11-151.98)/100000 person-years, and the incidence was 169.78 (95% CI 168.73-170.84)/100000 person-years in the group that received only TST. Conclusion TB occurred even in some patients who received LTBI prophylaxis in compliance with national guidelines. The incidence of TB in patients who received either the QFT-GIT plus TST prophylaxis strategy or the TST prophylaxis strategy alone was higher than the annual incidence of the general population of the Republic of Korea. It is not possible to conclude which of the LTBI prophylaxis strategies is superior.en_US
dc.description.sponsorshipThis work was supported by research funding from BMS Pharmaceutical Korea Limited and by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (no. HI10C2020).en_US
dc.language.isoenen_US
dc.publisherWILEY-BLACKWELLen_US
dc.subjectbiologic agenten_US
dc.subjectinterferon-gamma release assayen_US
dc.subjectlatent tuberculosis infectionen_US
dc.subjectQuantiFERON-TB Gold In-Tube testen_US
dc.subjecttuberculin skin testen_US
dc.titleEvaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agentsen_US
dc.typeArticleen_US
dc.relation.no3-
dc.relation.volume18-
dc.identifier.doi10.1111/1756-185X.12515-
dc.relation.page315-322-
dc.relation.journalINTERNATIONAL JOURNAL OF RHEUMATIC DISEASES-
dc.contributor.googleauthorKim, Jae-Hoon-
dc.contributor.googleauthorWon, Soyoung-
dc.contributor.googleauthorChoi, Chan-Bum-
dc.contributor.googleauthorSung, Yoon-Kyoung-
dc.contributor.googleauthorSong, Gwan Gyu-
dc.contributor.googleauthorBae, Sang Cheol-
dc.relation.code2015011779-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidscbae-
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE